[HTML][HTML] Hyperuricemia and endothelial function: From molecular background to clinical perspectives

T Maruhashi, I Hisatome, Y Kihara, Y Higashi - Atherosclerosis, 2018 - Elsevier
Uric acid is the end product of purine metabolism catalyzed by xanthine oxidase in humans.
In the process of purine metabolism, reactive oxygen species, including superoxide, are …

[引用][C] Hyperuricemia and endothelial function: From molecular background to clinical perspectives

T Maruhashi, I Hisatome, Y Kihara, Y Higashi - Atherosclerosis, 2018 - cir.nii.ac.jp
Hyperuricemia and endothelial function: From molecular background to clinical
perspectives | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Hyperuricemia and endothelial function: From molecular background to clinical perspectives

T Maruhashi, I Hisatome, Y Kihara… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Uric acid is the end product of purine metabolism catalyzed by xanthine oxidase in humans.
In the process of purine metabolism, reactive oxygen species, including superoxide, are …

Hyperuricemia and endothelial function: From molecular background to clinical perspectives

T Maruhashi, I Hisatome, Y Kihara… - …, 2018 - atherosclerosis-journal.com
Uric acid is the end product of purine metabolism catalyzed by xanthine oxidase in humans.
In the process of purine metabolism, reactive oxygen species, including superoxide, are …

Hyperuricemia and endothelial function: From molecular background to clinical perspectives.

T Maruhashi, I Hisatome, Y Kihara, Y Higashi - Atherosclerosis, 2018 - europepmc.org
Uric acid is the end product of purine metabolism catalyzed by xanthine oxidase in humans.
In the process of purine metabolism, reactive oxygen species, including superoxide, are …